未來趨勢（FUTURE TRENDS）
現代放射治療已進入一個嶄新而令人振奮的時代。精準的順形放射治療（conformal radiotherapy）正透過精密的三維 CT 為基礎的計畫與治療系統來給予。強度調控放射治療（intensity-modulated radiotherapy, IMRT）使腫瘤劑量得以提升、正常組織劑量得以下降。將 MRI 與功能性影像（如正子斷層造影 positron emission tomography, PET）整合進計畫系統，進一步強化了放射治療的精準給予，反射式共軛焦顯微鏡（reflectance confocal microscopy）亦可能如此。
關於急性放射性皮膚炎治療（Treatment of acute radiodermatitis）的額外圖片與表格，可於我們的電子書中取得（存取碼見封面內頁）。
- Bath-Hextall FJ, Perkins W, Bong J, Williams HC.
Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope. 2009;119:1994–1999.2. Withers HR. Biological basis of radiation therapy for
- Geist DE, Garcia-Moliner M, Fitzek MM. Perineural
Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;1:CD003412.19. Rowe DE, Carroll RJ, Day Jr CL. Long-term recurrence invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing treatment. Dermatol Surg. 2008;34:1642–1651.35. Mendenhall WM, Ferlito A, Takes RP, et al. Cutaneous rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15:315–328.20. Palmer VM, Wilson PR. Incompletely excised basal cell cancer. Lancet. 1992;339:156–163.3. Goldschmidt H, Breneman JC, Breneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol. 1994;30:157–182.4. Silva JJ, Tsang RW, Panzarella T, et al. Results of radio- head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol. 2012;48:918–922.36. Tomaszewski JM, Gavriel H, Link E, et al. Aggressive carcinoma: residual tumor rates at Mohs re-excision. Dermatol Surg. 2013;39:706–718.21. Liu FF, Maki E, Warde P, et al. A management approach to therapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982–1993. Int J Radiat Oncol Biol Phys. 2000;47:451–459.5. Khan FM. Quality of x-ray beams. In: Khan FM, ed. The behavior of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Laryngoscope. 2014;124:2043–2048.37. Veness MJ, Harris D. Role of radiotherapy in the incompletely excised basal cell carcinomas of the skin. Int J Radiat Oncol Biol Phys. 1991;20:423–428.22. Stevens JS, Murad F, Smile TD, et al. Validation of the
Physics of Radiation Therapy. 1st ed. Baltimore: Williams & Wilkins; 1984:110–120.6. Hernández-Machin B, Borrego L, Gil-Garcia M, management of organ transplant recipients diagnosed with non-melanoma skin cancers. Australas Radiol. 2006;51:12–20.38. Likhacheva A, Awan M, Barker CA, et al. Definitive and
2022 National Comprehensive Cancer Network risk stratification for cutaneous squamous cell carcinoma. JAMA Dermatol. 2023;159:728–735.23. Ruiz ES, Karia PS, Besaw R, Schmults CD. Performance
Hernández BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol. 2007;46:453–459.7. Pashazadeh A, Boese A, Friebe M. Radiation therapy postoperative radiation therapy for basal and squamous cell cancers of the skin: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2020;10:8–20.39. Bui DT, Chunilal A, Mehrara BJ, et al. Outcome of split- of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women’s Hospital Tumor Classification System for cutaneous squamous cell carcinoma. JAMA Dermatol. 2019;155: 819–825.24. Motley R, Kersey P, Lawrence C. Multiprofessional guide- techniques in the treatment of skin cancer: an overview of the current status and outlook. J Dermatolog Treat. 2019;8:831–839.8. van Hezewijk M, Creutzberg CL, Putter H, et al. Efficacy thickness skin grafts after external beam radiotherapy. Ann Plast Surg. 2004;52:551–557.40. Veness MJ, Palme CE, Morgan GJ. Merkel cell carcinoma:
a review of management. Curr Opin Otolaryngol Head Neck Surg. 2008;16:170–174.41. Howle J, Hughes M, Gebski V, Veness MJ. Merkel cell lines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2002;146:18–25.25. Najim M, Cross S, Gebski V, et al. Early-stage squamous of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiother Oncol. 2010;95:245–249.9. Shah C, Ouhib Z, Kamrava M, et al. ABS Consensus carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. J Am Acad Dermatol. 2012;67:33–40.42. Hruby G, Scolyer RA, Thompson JF, et al. The important cell carcinoma of the lip: the Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection. Head Neck. 2012;35:1426–1430.26. Schmitt AR, Brewer JD, Bordeaux JS, Baum CL. Staging
Statement: The American Brachytherapy Society consensus statement for skin brachytherapy. Brachytherapy. 2020;19:415–426.10. Tom MC, Hepel JT, Patel R, et al. Special Section on
Intraoperative Radiation Therapy and Eclectronic Brachytherapy. The American Brachytherapy Society consensus statement for electronic brachytherapy. Brachytherapy. 2019;18:292–298.11. Ouhib Z, Kasper M, Calatayud JP, et al. Aspects of role of radiation treatment in the management of Merkel cell carcinoma. Br J Dermatol. 2013;169:975–982.43. Veness M, Foote M, Gebski V, Poulsen M. The role for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. J Am Acad Dermatol. 2014;150:19–24.27. Dessinioti C, Stratigos AJ. Overview of guideline recom- dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. Brachytherapy. 2015;14:840–858.12. Alam M, Nanda S, Mittal B, et al. The use of brachy- of radiotherapy alone in patients with Merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78:703–709.44. Veness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg. 2005;75:275–281.45. Clark JC, Veness MJ, Gilbert R, et al. Merkel cell carcinoma mendations for the management of high-risk and advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol. 2022;36(Suppl1):11–18.28. Brodland DG, Zitelli JA. Surgical margins for excision of therapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol. 2011;65:377–388.12a. Berrington de Gonzalez A, Gilbert E, Curtis R, et al.
of the head and neck: is adjuvant radiotherapy necessary? Head Neck. 2007;29:249–257.46. Foote M, Harvey J, Porceddu S, et al. Effect of radio- primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27:241–248.29. Kwan W, Wilson D, Moravan V. Radiotherapy for locally
Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys. 2013;86:224–233.13. Huang Q, Veness M, Richards S. The role of adjuvant therapy dose and volume on relapse in Merkel cell cancer of the skin. Int J Radiat Oncol Biol Phys. 2010;77:677–684.47. Veness M, Cooper S. Treatment of cutaneous angio- advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys. 2004;60:406–411.30. Babington S, Veness MJ, Cakir B, et al. Squamous cell sarcomas of the head and neck. Australas Radiol. 1995;39:277–281.48. Spratt DE, Gordon-Spratt EA, Romanyshyn JC, et al.
carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision? ANZ J Surg. 2003;73:621–625.31. Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous radiotherapy in recurrent keloids. Australas J Dermatol. 2004;45:162–166.14. Renz P, Hasan S, Gresswell S, et al. Dose effect in adjuvant radiation therapy for the treatment of resected keloids. Int J Radiation Oncol Biol Phys. 2018;102:149–154.15. Lukas-Vanderspek LA, Pond GR, Wells W, Tsang RW.
Radiation therapy in treatment of cutaneous angiosarcoma of the head and neck. World J Surg Med Rad Oncol. 2013;2:6–18.49. Caccialanza M, Marca S, Piccinno R, Eulisse G.
head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–631.32. Wang JT, Palme CE, Morgan GJ, et al. Predictors of
Radiation therapy for Bowen’s disease of the skin. Int J Radiat Oncol Biol Phys. 2005;63:505–510.16. Fogarty GB, Hong A, Scolyer RA, et al. Radiotherapy for
Radiotherapy of classic and human immunodeficiency virus-related Kaposi’s sarcoma: results in 1482 lesions. J Eur Acad Dermatol Venereol. 2008;22:297–302.50. Lukawska J, Cottrill C, Bower M. The changing role of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck. 2012;34:1524–1528.33. Buchanan L, De’Ambrosis B, De’Ambrosis K, et al.
lentigo maligna: a literature review and recommendations for treatment. Br J Dermatol. 2014;170:52–58.17. Huynh NT, Veness MJ. Radiotherapy for lentigo radiotherapy in AIDS-related malignancies. Clin Oncol. 2003;15:2–6.51. Smith BD, Glusac EJ, McNiff JM, et al. Primary cutaneous
Defining incidental perineural invasion: the need for a national registry. Australas J Dermatol. 2014;55:107–110.
maligna. Arch Dermatol. 2002;138:981–982.
B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research